| Pamela Jean Bruce, RPH | |
|
411 N Main St, Moscow, ID 83843-2630 | |
| (208) 882-0900 | |
| (208) 883-1407 |
| Full Name | Pamela Jean Bruce |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 411 N Main St, Moscow, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356621254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P4766 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pamela Jean Bruce, RPH 411 N Main St, Moscow, ID 83843-2630 Ph: (208) 882-0900 | Pamela Jean Bruce, RPH 411 N Main St, Moscow, ID 83843-2630 Ph: (208) 882-0900 |
News Archive
The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Using a special type of magnetic resonance imaging, researchers have found that soldiers who suffered mild traumatic brain injury induced by blast exposure exhibit long-term brain differences, according to a study being presented today at the annual meeting of the Radiological Society of North America.
But Cindy Mann says that she is confident states will be ready by October to cover the new enrollees who will gain access to the safety net program.
Researchers at Baylor College of Medicine in Houston have developed sophisticated DNA analyses that can detect disabilities as birth defects, epilepsy or developmental delays. They note that about 25 percent of genetic material inherited from their mother was the same as material inherited from their father. This denoted incest. This has triggered ethical debates over how these inadvertent findings should be handled.
Isotretinoin (also known as Accutane) is a drug used to treat severe acne, but it can cause birth defects when taken by pregnant women. Because of these risks, the U.S. Food and Drug Administration and Roche Pharmaceuticals (Accutane's manufacturer) developed a voluntary pregnancy prevention program (PPP) in 1988 to try and prevent conception in women taking the drug.
› Verified 2 days ago
Riley Hurst, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1320 S Blaine St, Moscow, ID 83843 Phone: 208-882-2663 Fax: 208-882-0297 | |
Dr. Heather Ann Smith, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 414 N Main St, Moscow, ID 83843 Phone: 208-882-6076 | |
Dr. Keri Noel Sullivan-walker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St Ste 120, Moscow, ID 83843 Phone: 208-848-8300 Fax: 208-848-8304 | |
Dr. Laura Buchanan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 414 N Main St, Moscow, ID 83843 Phone: 208-882-6076 Fax: 208-882-6846 | |
Dr. Bertha Futse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2470 W Pullman Rd, Moscow, ID 83843 Phone: 208-882-1344 Fax: 208-882-5886 | |
Tanya Marie Snodgrass, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 S. Main St., Attn: Pharmacy, Moscow, ID 83843 Phone: 208-883-2236 | |
Mrs. Heidi M Poxleitner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1810 W Pullman Rd, Moscow, ID 83843 Phone: 208-882-3583 Fax: 208-883-8280 |